Supernus Pharmaceuticals ... (SUPN)
31.77
-0.29 (-0.90%)
At close: Mar 03, 2025, 3:59 PM
32.30
1.67%
Pre-market: Mar 04, 2025, 06:25 AM EST
Supernus Pharmaceuticals Revenue
Supernus Pharmaceuticals reported an annual revenue of $607.52M, reflecting a -8.95% growth. For the quarter ending September 30, 2024, Supernus Pharmaceuticals generated $175.69M in revenue.
Revenue (ttm)
$607.52M
Revenue Growth
-8.95%
Price / Sales Ratio
2.6
Revenue / Employee
$931.78K
Employees
652
Market Cap
1.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2023 | 607.52M | -8.95% |
Dec 31, 2022 | 667.24M | +15.09% |
Dec 31, 2021 | 579.77M | +11.41% |
Dec 31, 2020 | 520.4M | n/a |